These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 20850205)
1. Structure-based optimization and biological evaluation of human 20α-hydroxysteroid dehydrogenase (AKR1C1) salicylic acid-based inhibitors. El-Kabbani O; Scammells PJ; Day T; Dhagat U; Endo S; Matsunaga T; Soda M; Hara A Eur J Med Chem; 2010 Nov; 45(11):5309-17. PubMed ID: 20850205 [TBL] [Abstract][Full Text] [Related]
2. Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1). El-Kabbani O; Scammells PJ; Gosling J; Dhagat U; Endo S; Matsunaga T; Soda M; Hara A J Med Chem; 2009 May; 52(10):3259-64. PubMed ID: 19397269 [TBL] [Abstract][Full Text] [Related]
3. Probing the inhibitor selectivity pocket of human 20α-hydroxysteroid dehydrogenase (AKR1C1) with X-ray crystallography and site-directed mutagenesis. El-Kabbani O; Dhagat U; Soda M; Endo S; Matsunaga T; Hara A Bioorg Med Chem Lett; 2011 Apr; 21(8):2564-7. PubMed ID: 21414777 [TBL] [Abstract][Full Text] [Related]
4. Factorizing the role of a critical leucine residue in the binding of substrate to human 20alpha-hydroxysteroid dehydrogenase (AKR1C1): molecular modeling and kinetic studies of the Leu308Val mutant enzyme. Dhagat U; Endo S; Soda M; Hara A; El-Kabbani O Bioorg Med Chem Lett; 2010 Sep; 20(17):5274-6. PubMed ID: 20656485 [TBL] [Abstract][Full Text] [Related]
5. A salicylic acid-based analogue discovered from virtual screening as a potent inhibitor of human 20alpha-hydroxysteroid dehydrogenase. Dhagat U; Carbone V; Chung RP; Matsunaga T; Endo S; Hara A; El-Kabbani O Med Chem; 2007 Nov; 3(6):546-50. PubMed ID: 18045204 [TBL] [Abstract][Full Text] [Related]
6. Inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1). El-Kabbani O; Dhagat U; Hara A J Steroid Biochem Mol Biol; 2011 May; 125(1-2):105-11. PubMed ID: 21050889 [TBL] [Abstract][Full Text] [Related]
7. Derivatives of pyrimidine, phthalimide and anthranilic acid as inhibitors of human hydroxysteroid dehydrogenase AKR1C1. Brozic P; Cesar J; Kovac A; Davies M; Johnson AP; Fishwick CW; Lanisnik Rizner T; Gobec S Chem Biol Interact; 2009 Mar; 178(1-3):158-64. PubMed ID: 19007763 [TBL] [Abstract][Full Text] [Related]
8. Characterization of homogeneous recombinant rat ovarian 20alpha-hydroxysteroid dehydrogenase: fluorescent properties and inhibition profile. Ma H; Penning TM Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):853-9. PubMed ID: 10417353 [TBL] [Abstract][Full Text] [Related]
9. Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3. Beranič N; Gobec S; Rižner TL Chem Biol Interact; 2011 May; 191(1-3):227-33. PubMed ID: 21182831 [TBL] [Abstract][Full Text] [Related]
10. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Ji Q; Aoyama C; Nien YD; Liu PI; Chen PK; Chang L; Stanczyk FZ; Stolz A Cancer Res; 2004 Oct; 64(20):7610-7. PubMed ID: 15492289 [TBL] [Abstract][Full Text] [Related]
11. Selective and potent inhibitors of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone. Higaki Y; Usami N; Shintani S; Ishikura S; El-Kabbani O; Hara A Chem Biol Interact; 2003 Feb; 143-144():503-13. PubMed ID: 12604236 [TBL] [Abstract][Full Text] [Related]
12. Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKR1C1. Brozic P; Smuc T; Gobec S; Rizner TL Mol Cell Endocrinol; 2006 Oct; 259(1-2):30-42. PubMed ID: 16962702 [TBL] [Abstract][Full Text] [Related]
13. Structure of aldehyde reductase in ternary complex with coenzyme and the potent 20alpha-hydroxysteroid dehydrogenase inhibitor 3,5-dichlorosalicylic acid: implications for inhibitor binding and selectivity. Carbone V; Chung R; Endo S; Hara A; El-Kabbani O Arch Biochem Biophys; 2008 Nov; 479(1):82-7. PubMed ID: 18782556 [TBL] [Abstract][Full Text] [Related]
14. New cyclopentane derivatives as inhibitors of steroid metabolizing enzymes AKR1C1 and AKR1C3. Stefane B; Brozic P; Vehovc M; Rizner TL; Gobec S Eur J Med Chem; 2009 Jun; 44(6):2563-71. PubMed ID: 19237229 [TBL] [Abstract][Full Text] [Related]
15. Selectivity determinants of inhibitor binding to human 20alpha-hydroxysteroid dehydrogenase: crystal structure of the enzyme in ternary complex with coenzyme and the potent inhibitor 3,5-dichlorosalicylic acid. Dhagat U; Endo S; Sumii R; Hara A; El-Kabbani O J Med Chem; 2008 Aug; 51(15):4844-8. PubMed ID: 18620380 [TBL] [Abstract][Full Text] [Related]
16. Human 20alpha-hydroxysteroid dehydrogenase: crystallographic and site-directed mutagenesis studies lead to the identification of an alternative binding site for C21-steroids. Couture JF; Legrand P; Cantin L; Luu-The V; Labrie F; Breton R J Mol Biol; 2003 Aug; 331(3):593-604. PubMed ID: 12899831 [TBL] [Abstract][Full Text] [Related]
17. Alanine scanning mutagenesis of the testosterone binding site of rat 3 alpha-hydroxysteroid dehydrogenase demonstrates contact residues influence the rate-determining step. Heredia VV; Cooper WC; Kruger RG; Jin Y; Penning TM Biochemistry; 2004 May; 43(19):5832-41. PubMed ID: 15134457 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10. Soda M; Hu D; Endo S; Takemura M; Li J; Wada R; Ifuku S; Zhao HT; El-Kabbani O; Ohta S; Yamamura K; Toyooka N; Hara A; Matsunaga T Eur J Med Chem; 2012 Feb; 48():321-9. PubMed ID: 22236472 [TBL] [Abstract][Full Text] [Related]
19. Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone. Möller G; Deluca D; Gege C; Rosinus A; Kowalik D; Peters O; Droescher P; Elger W; Adamski J; Hillisch A Bioorg Med Chem Lett; 2009 Dec; 19(23):6740-4. PubMed ID: 19836949 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity study in the class of 6-(3'-hydroxyphenyl)naphthalenes leading to an optimization of a pharmacophore model for 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitors. Marchais-Oberwinkler S; Frotscher M; Ziegler E; Werth R; Kruchten P; Messinger J; Thole H; Hartmann RW Mol Cell Endocrinol; 2009 Mar; 301(1-2):205-11. PubMed ID: 18950679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]